Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 18 | 0 | 0 | 283 |
| Cost of Goods | N/A | N/A | N/A | 0 | 1,055 |
| Gross Profit | N/A | 18 | N/A | 0 | -772 |
| Operating Expenses | 23,453 | 23,771 | 22,433 | 24,017 | 20,372 |
| Operating Income | -23,453 | -23,753 | -22,433 | -24,017 | -21,089 |
| Other Income | 1,201 | 1,276 | 989 | 426 | 556 |
| Pre-tax Income | -22,252 | -22,477 | -21,444 | -23,591 | -20,533 |
| Net Income Continuous | -22,252 | -22,477 | -21,444 | -23,716 | -20,533 |
| Net Income | $-22,252 | $-22,477 | $-21,444 | $-23,716 | $-20,533 |
| EPS Basic Total Ops | -1.06 | -1.08 | -1.11 | -1.50 | -1.28 |
| EPS Basic Continuous Ops | -1.06 | -1.08 | -1.11 | -1.51 | -1.28 |
| EPS Diluted Total Ops | -1.06 | -1.08 | -1.11 | -1.50 | -1.28 |
| EPS Diluted Continuous Ops | -1.06 | -1.08 | -1.11 | -1.51 | -1.28 |
| EBITDA(a) | $-23,718 | $-23,860 | $-22,370 | $-23,949 | $-21,031 |